Literature DB >> 28319088

Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors.

Huipeng Li1, Elise T Courtois1,2, Debarka Sengupta1,3, Yuliana Tan1,2, Kok Hao Chen4, Jolene Jie Lin Goh4, Say Li Kong5, Clarinda Chua6, Lim Kiat Hon7, Wah Siew Tan8, Mark Wong8, Paul Jongjoon Choi4, Lawrence J K Wee9, Axel M Hillmer5, Iain Beehuat Tan5,6,10, Paul Robson2,11,12,13, Shyam Prabhakar1.   

Abstract

Intratumoral heterogeneity is a major obstacle to cancer treatment and a significant confounding factor in bulk-tumor profiling. We performed an unbiased analysis of transcriptional heterogeneity in colorectal tumors and their microenvironments using single-cell RNA-seq from 11 primary colorectal tumors and matched normal mucosa. To robustly cluster single-cell transcriptomes, we developed reference component analysis (RCA), an algorithm that substantially improves clustering accuracy. Using RCA, we identified two distinct subtypes of cancer-associated fibroblasts (CAFs). Additionally, epithelial-mesenchymal transition (EMT)-related genes were found to be upregulated only in the CAF subpopulation of tumor samples. Notably, colorectal tumors previously assigned to a single subtype on the basis of bulk transcriptomics could be divided into subgroups with divergent survival probability by using single-cell signatures, thus underscoring the prognostic value of our approach. Overall, our results demonstrate that unbiased single-cell RNA-seq profiling of tumor and matched normal samples provides a unique opportunity to characterize aberrant cell states within a tumor.

Entities:  

Mesh:

Year:  2017        PMID: 28319088     DOI: 10.1038/ng.3818

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  51 in total

1.  Improved ancestry estimation for both genotyping and sequencing data using projection procrustes analysis and genotype imputation.

Authors:  Chaolong Wang; Xiaowei Zhan; Liming Liang; Gonçalo R Abecasis; Xihong Lin
Journal:  Am J Hum Genet       Date:  2015-05-28       Impact factor: 11.025

2.  Cancer cell invasion driven by extracellular matrix remodeling is dependent on the properties of cancer-associated fibroblasts.

Authors:  Shinya Neri; Hiroko Hashimoto; Hiroaki Kii; Hirotada Watanabe; Kenkichi Masutomi; Takeshi Kuwata; Hiroshi Date; Masahiro Tsuboi; Koichi Goto; Atsushi Ochiai; Genichiro Ishii
Journal:  J Cancer Res Clin Oncol       Date:  2015-09-15       Impact factor: 4.553

3.  The prognostic landscape of genes and infiltrating immune cells across human cancers.

Authors:  Andrew J Gentles; Aaron M Newman; Chih Long Liu; Scott V Bratman; Weiguo Feng; Dongkyoon Kim; Viswam S Nair; Yue Xu; Amanda Khuong; Chuong D Hoang; Maximilian Diehn; Robert B West; Sylvia K Plevritis; Ash A Alizadeh
Journal:  Nat Med       Date:  2015-07-20       Impact factor: 53.440

Review 4.  Motexafin gadolinium: a redox-active tumor selective agent for the treatment of cancer.

Authors:  Andrew M Evens
Journal:  Curr Opin Oncol       Date:  2004-11       Impact factor: 3.645

5.  A colorectal cancer classification system that associates cellular phenotype and responses to therapy.

Authors:  Anguraj Sadanandam; Costas A Lyssiotis; Krisztian Homicsko; Eric A Collisson; William J Gibb; Stephan Wullschleger; Liliane C Gonzalez Ostos; William A Lannon; Carsten Grotzinger; Maguy Del Rio; Benoit Lhermitte; Adam B Olshen; Bertram Wiedenmann; Lewis C Cantley; Joe W Gray; Douglas Hanahan
Journal:  Nat Med       Date:  2013-04-14       Impact factor: 53.440

6.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

Review 7.  Cancer-associated fibroblasts as targets for immunotherapy.

Authors:  Sunitha Kakarla; Xiao-Tong Song; Stephen Gottschalk
Journal:  Immunotherapy       Date:  2012-11       Impact factor: 4.196

8.  MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data.

Authors:  Greg Finak; Andrew McDavid; Masanao Yajima; Jingyuan Deng; Vivian Gersuk; Alex K Shalek; Chloe K Slichter; Hannah W Miller; M Juliana McElrath; Martin Prlic; Peter S Linsley; Raphael Gottardo
Journal:  Genome Biol       Date:  2015-12-10       Impact factor: 13.583

9.  Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance.

Authors:  Kari R Fischer; Anna Durrans; Sharrell Lee; Jianting Sheng; Fuhai Li; Stephen T C Wong; Hyejin Choi; Tina El Rayes; Seongho Ryu; Juliane Troeger; Robert F Schwabe; Linda T Vahdat; Nasser K Altorki; Vivek Mittal; Dingcheng Gao
Journal:  Nature       Date:  2015-11-11       Impact factor: 49.962

10.  De Novo Prediction of Stem Cell Identity using Single-Cell Transcriptome Data.

Authors:  Dominic Grün; Mauro J Muraro; Jean-Charles Boisset; Kay Wiebrands; Anna Lyubimova; Gitanjali Dharmadhikari; Maaike van den Born; Johan van Es; Erik Jansen; Hans Clevers; Eelco J P de Koning; Alexander van Oudenaarden
Journal:  Cell Stem Cell       Date:  2016-06-23       Impact factor: 24.633

View more
  308 in total

1.  Single-cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma.

Authors:  Hongping Zheng; Yotsawat Pomyen; Maria Olga Hernandez; Caiyi Li; Ferenc Livak; Wei Tang; Hien Dang; Tim F Greten; Jeremy L Davis; Yongmei Zhao; Monika Mehta; Yelena Levin; Jyoti Shetty; Bao Tran; Anuradha Budhu; Xin Wei Wang
Journal:  Hepatology       Date:  2018-05-09       Impact factor: 17.425

2.  Integrated Single-Cell Analysis Maps the Continuous Regulatory Landscape of Human Hematopoietic Differentiation.

Authors:  Jason D Buenrostro; M Ryan Corces; Caleb A Lareau; Beijing Wu; Alicia N Schep; Martin J Aryee; Ravindra Majeti; Howard Y Chang; William J Greenleaf
Journal:  Cell       Date:  2018-04-26       Impact factor: 41.582

3.  Global prediction of chromatin accessibility using small-cell-number and single-cell RNA-seq.

Authors:  Weiqiang Zhou; Zhicheng Ji; Weixiang Fang; Hongkai Ji
Journal:  Nucleic Acids Res       Date:  2019-11-04       Impact factor: 16.971

Review 4.  Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.

Authors:  Ugo Testa; Elvira Pelosi; Germana Castelli
Journal:  Med Sci (Basel)       Date:  2018-04-13

5.  Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts.

Authors:  Mohan Bolisetty; Pasquale Laise; William F Flynn; Ela Elyada; Elise T Courtois; Richard A Burkhart; Jonathan A Teinor; Pascal Belleau; Giulia Biffi; Matthew S Lucito; Santhosh Sivajothi; Todd D Armstrong; Dannielle D Engle; Kenneth H Yu; Yuan Hao; Christopher L Wolfgang; Youngkyu Park; Jonathan Preall; Elizabeth M Jaffee; Andrea Califano; Paul Robson; David A Tuveson
Journal:  Cancer Discov       Date:  2019-06-13       Impact factor: 39.397

Review 6.  Regulation of breast cancer metastasis signaling by miRNAs.

Authors:  Belinda J Petri; Carolyn M Klinge
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

Review 7.  Machine learning approaches to drug response prediction: challenges and recent progress.

Authors:  George Adam; Ladislav Rampášek; Zhaleh Safikhani; Petr Smirnov; Benjamin Haibe-Kains; Anna Goldenberg
Journal:  NPJ Precis Oncol       Date:  2020-06-15

8.  SAME-clustering: Single-cell Aggregated Clustering via Mixture Model Ensemble.

Authors:  Ruth Huh; Yuchen Yang; Yuchao Jiang; Yin Shen; Yun Li
Journal:  Nucleic Acids Res       Date:  2020-01-10       Impact factor: 16.971

Review 9.  Tumour heterogeneity and the evolutionary trade-offs of cancer.

Authors:  Jean Hausser; Uri Alon
Journal:  Nat Rev Cancer       Date:  2020-02-24       Impact factor: 60.716

Review 10.  The mesenchymal context in inflammation, immunity and cancer.

Authors:  Vasiliki Koliaraki; Alejandro Prados; Marietta Armaka; George Kollias
Journal:  Nat Immunol       Date:  2020-08-03       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.